Forfang K, Simonsen S
Medical Department B, National Hospital of Norway, University of Oslo.
Eur J Clin Pharmacol. 1989;37(1):23-7. doi: 10.1007/BF00609418.
To investigate if the intrinsic sympathomimetic activity of pindolol could modify its beta-blocking effects on the responses to an adrenaline infusion, 10 healthy volunteers were studied. At an interval of 1-4 weeks each subject received pindolol and atenolol in randomized order before the infusion of adrenaline 0.06 microgram.kg-1.min-1. Pindolol prevented hypokalaemia and significantly decreased the heart rate during the adrenaline infusion. These effects were not observed after atenolol. The diastolic blood pressure was slightly increased during the infusion of adrenaline after pindolol, whereas it remained unchanged after atenolol.
为研究吲哚洛尔的内在拟交感活性是否会改变其对肾上腺素输注反应的β受体阻滞作用,对10名健康志愿者进行了研究。在输注0.06微克·千克⁻¹·分钟⁻¹肾上腺素前,每位受试者每隔1 - 4周按随机顺序接受吲哚洛尔和阿替洛尔。吲哚洛尔可预防低钾血症,并在肾上腺素输注期间显著降低心率。阿替洛尔用药后未观察到这些效应。吲哚洛尔用药后在肾上腺素输注期间舒张压略有升高,而阿替洛尔用药后舒张压保持不变。